Prepulse inhibition in rats with temporary inhibition/inactivation of ventral or dorsal hippocampus

Pharmacology Biochemistry and Behavior

Volumn 73, Issue 4, 2002, Pages 929-940

  Zhang, W N ^a   Bast, T ^a   Feldon, J ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Clozapine; Haloperidol; Muscimol; Neuroleptics; Prepulse inhibition; Schizophrenia; Sensorimotor gating; Startle; TTX; Ventral and dorsal hippocampus

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; CLOZAPINE; HALOPERIDOL; MUSCIMOL; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; CHANNEL GATING; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT;

ANIMALS; GABA AGONISTS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCIMOL; RATS; RATS, WISTAR; SODIUM CHANNEL BLOCKERS; STARTLE REACTION; TETRODOTOXIN;

RATTUS NORVEGICUS;

EID: 0036829133     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00936-X     Document Type: Article

References (70)

1. Amaral D.G., Witter M.P. Hippocampal formation. Paxinos G. The rat nervous system. 1995;443-493 Academic Press, San Diego, CA.
2. Bakshi V., Geyer M.A. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci. 18:1998;8394-8401.
3. Bakshi V., Geyer M.A. Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats. Neuroscience. 92:1999;113-121.
4. Bast T., Zhang W-N, Feldon J., White I.M. Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats. Pharmacol Biochem Behav. 67:2000;647-658.
5. Bast T., Zhang W-N, Feldon J. Hippocampus and classical fear conditioning. Hippocampus. 11:2001;828-831.
6. A receptor antagonist picrotoxin. Psychopharmacology. 156:2001;225-233.
7. A agonist muscimol. Exp Brain Res. 139:2001;39-52.
8. Bast T., Zhang W-N, Heidbreder C., Feldon J. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience. 103:2001;325-335.
9. Bast T, Zhang W-N, Feldon J. Dorsal hippocampus and classical fear conditioning: The effects of local NMDA-receptor blockade and stimulation. Hippocampus, in press.
10. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Rev. 31:2000;251-269.
11. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 156:2001;234-258.
12. Brudzynski S.M., Gibson C.J. Release of dopamine in the nucleus accumbens caused by stimulation of the subiculum in freely moving rats. Brain Res Bull. 42:1997;303-308.
13. Bures J., Buresova O. Reversible lesions allow reinterpretation of system level studies of brain mechanisms of behavior. Conc Neurosci. 1:1990;69-89.
14. Caine S.B., Geyer M.A., Swerdlow N.R. Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of the startle reflex in rats. Psychopharmacology. 105:1991;347-354.
15. Caine S.B., Geyer M.A., Swerdlow N.R. Hippocampal modulation of acoustic startle and prepulse inhibition in the rat. Pharmacol Biochem Behav. 43:1992;1201-1208.
16. Caine S.B., Humby T., Robbins T.W., Everitt B.J. Behavioral effects of psychomotor stimulants in rats with dorsal or ventral subiculum lesions: locomotion, cocaine self-administration, and prepulse inhibition of startle. Behav Neurosci. 115:2001;880-894.
17. Ellenbroek B.A., Budde S., Cools A.R. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience. 75:1996;535-542.
18. Feldon J., Bast T., Zhang W-N Temporary inhibition or inactivation of the dorsal or ventral hippocampus disrupts prepulse inhibition. Soc Neurosci Abstr. 27:2001;851.9.
19. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology. 156:2001;117-154.
20. Gothelf D., Soreni N., Nachman R.P., Tyano S., Hiss Y., Reiner O., Weizman A. Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia. Eur Neuropsychopharmacol. 10:2000;389-395.
21. Grace A.A. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev. 31:2000;330-341.
22. Graham F.K. The more or less startling effects of weak prestimulation. Psychophysiology. 12:1975;238-248.
23. Gray J.A., Feldon J., Rawlins J.N.P., Hemsley D.R., Smith A.D. The neuropsychology of schizophrenia. Behav Brain Sci. 14:1991;1-84.
24. Groenewegen H.J., Vermeulen-Van der Zee E., Te Kortschot A., Witter M.P. Organization of the projections from the subiculum to the ventral striatum in the rat: a study using anterograde transport of Phaseolus vulgaris-leucoagglutinin. Neuroscience. 23:1987;103-120.
25. Gurden H., Takita M., Jay T.M. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J Neurosci. 20:2000;RC106. (1-5).
26. Hajos F., Garthwaite G., Garthwaite J. Reversible and irreversible neuronal damage caused by excitatory amino acid analogues in rat cerebellar slices. Neuroscience. 18:1986;417-436.
27. Halim N.D., Swerdlow N.R. Distributed neurodegenerative changes 2-28 days after ventral hippocampal excitotoxic lesions in rats. Brain Res. 873:2000;60-74.
28. Hamm A.O., Weike A.I., Schupp H.T. The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues. Psychopharmacology. 156:2001;259-265.
29. Harrison P.J. The neuropathology of schizophrenia. A critical review of data and their interpretation. Brain. 122:1999;593-624.
30. Harrison P.J., Eastwood S.L. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus. 11:2001;508-519.
31. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus. 11:2001;520-528.
32. Kelley A.E., Domesick V.B. The distribution of the projections from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience. 7:1982;2321-2335.
33. Kemble E.D., Ison J.R. Limbic lesions and the inhibition of startle reactions in the rat by conditions of preliminary stimulation. Physiol Behav. 7:1971;925-928.
34. Klarner A., Koch M., Schnitzler H.U. Induction of Fos-protein in the forebrain and disruption of sensorimotor gating following N-methyl-D-aspartate infusion into the ventral hippocampus of the rat. Neuroscience. 84:1998;443-452.
35. Koch M. The neurobiology of startle. Prog Neurobiol. 59:1999;107-128.
36. Lacroix L., Broersen L.M., Feldon J., Weiner I. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav Brain Res. 107:2000;111-121.
37. Legault M., Wise R.A. Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area. Eur J Neurosci. 13:2001;819-823.
38. Le Pen G., Grottick A.J., Higgins G.A., Martin J.R., Jenck F., Moreau J-L Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia. Behav Pharmacol. 11:2000;257-268.
39. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron. 28:2000;325-334.
40. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
41. Lomber S.G. The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function. J Neurosci Methods. 86:1999;109-117.
42. Martin J.H. Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat. Neursosci Lett. 127:1991;160-164.
43. Mitchell S.N., Yee B.K., Feldon J., Gray J.A., Rawlins J.N.P. Activation of the retrohippocampal region in the rat causes dopamine release in the nucleus accumbens: disruption by fornix section. Eur J Pharmacol. 407:2000;131-138.
44. Norris C.M., Blumenthal T.D. A relationship between inhibition of the acoustic startle response and the protection of prepulse processing. Psychobiology. 24:1996;160-168.
45. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
46. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1998;Academic Press, New York.
47. Pezze M., Bast T., Feldon J. Effects of dopamine receptor stimulation or blockade in the medial prefrontal cortex on locomotor activity, sensorimotor gating, and conditioned fear. Behav Pharmacol. 12(Suppl 1):2001;S77.
48. Pitkänen A., Pikkarainen M., Nurminen N., Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann NY Acad Sci. 911:2000;369-391.
49. Pouzet B., Feldon J., Veenman L., Yee B.K., Richmond M., Rawlins J.N.P., Weiner I. The effects of hippocampal and fimbria-fornix lesions on prepulse inhibition. Behav Neurosci. 113:1999;668-981.
50. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat and anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol. 290:1989;213-242.
51. Stein D.G. The ghost in the machine is still there. Behav Brain Sci. 2:1979;346-348.
52. Swanson L.W., Cowan W.M. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J Comp Neurol. 172:1977;49-84.
53. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the sensorimotor gating disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 122:1995;27-34.
54. Swerdlow N.R., Braff D.L., Geyer M.A. Animal models of sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol. 11:2000;185-204.
55. Swerdlow N.R., Taaid N., Halim N., Randolph E., Kim Y.K., Auerbach P. Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: a parametric assessment. Neuroscience. 96:2000;523-536.
56. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology. 156:2001;194-215.
57. Swerdlow N.R., Hanlon F.M., Henning L., Kim Y.K., Gaudet I., Halim N.D. Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization. Brain Res. 898:2001;195-203.
58. 1 receptors. Psychopharmacology. 151:2000;242-251.
59. Verwer R.W.H., Meijer R.J., Van Uum H.F.M., Witter M.P. Collateral projections from the rat hippocampal formation to the lateral and medial prefrontal cortex. Hippocampus. 7:1997;397-402.
60. Wan F.J., Swerdlow N.R. The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat. Neuroscience. 76:1997;715-724.
61. Wan F.J., Caine S.B., Swerdlow N.R. The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity. Eur J Pharmacol. 314:1996;9-18.
62. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry. 45:1999;395-402.
63. Winer B.J. Statistical principles in experimental design. 1971;McGraw Hill, New York.
64. Zavitsanou K., Cranney J., Richardson R. Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat. Pharmacol Biochem Behav. 63:1999;55-61.
65. Zham D.S. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev. 24:2000;85-105.
66. Zhang W-N, Pouzet B., Jongen-Rêlo A.L., Weiner I., Feldon J. Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. NeuroReport. 10:1999;2533-2538.
67. Zhang J., Forkstam C., Engel J.A., Svensson L. Role of dopamine in prepulse inhibition of acoustic startle. Psychopharmacology. 149:2000;181-188.
68. Zhang W-N, Bast T., Feldon J. Microinfusion of the noncompetitive N-methyl-D-aspartate antagonist MK-801 (dizocilpine) into the dorsal hippocampus of Wistar rats does not affect latent inhibition and prepulse inhibition but increases startle reaction and locomotor activity. Neuroscience. 101:2000;589-599.
69. Zhang W-N, Bast T., Feldon J. Effects of hippocampal N-methyl-D-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus. Behav Neurosci. 116:2002;72-84.
70. Zhuravin I.A., Bures J. Extent of the tetrodotoxin induced blockade examined by pupillary paralysis elicited by intracerebral injection of the drug. Exp Brain Res. 83:1991;687-690.